Day: November 5, 2021

Solutions designed to help increase transit ridership while safeguarding public health FLORHAM PARK, N.J., Nov. 05, 2021 (GLOBE NEWSWIRE) — Conduent Transportation, a global business unit of Conduent Incorporated (Nasdaq: CNDT), will highlight a range of solutions to advance safe public transit, fleet management, ticketing and fare collection at the 2021 APTA TRANSform Conference and Expo, November 8-10, in Orlando, Florida. These solutions include contactless technologies designed to help increase transit ridership, while safeguarding public health and helping transportation agencies create smarter cities and better traveling experiences. The event, hosted by the American Public Transportation Association (APTA), is held every three years to connect transit industry leaders, influencers and decisionmakers from around the world...

NEW YORK, Nov. 05, 2021 (GLOBE NEWSWIRE) — The Vita Coco Company, Inc. (NASDAQ:COCO), a leading high-growth platform of better-for-you brands, today announced that it will report financial results for the third quarter ended September 30, 2021 on Thursday, November 11, 2021 after market close. The Company will host a conference call and webcast to discuss these results at 5:00 p.m. ET on the same day. Investors interested in listening to the conference call may do so by dialing (800) 547-1866 or for international callers by dialing (224) 619-3907, conference ID 2788336. A replay of the conference call will be available through November 25, 2021 by dialing (855) 859-2056 or for international callers by dialing (404) 537-3406, conference ID 2788336. The live audio webcast will be accessible in the “Events” section of the Company’s...

BELGRADE, Mont., Nov. 05, 2021 (GLOBE NEWSWIRE) — Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced that it will release its financial results for the third quarter ended September 30, 2021, before the open of the financial markets on Friday, November 12, 2021. Sean Browne, President and Chief Executive Officer, and Greg Jensen, Vice President, Finance and Chief Financial Officer, will host a conference call on Friday, November 12 at 9:00 AM ET to review results. Conference DetailsConference Date: Friday, November 12, 2021 – 9:00 AM ETConference dial-in: 866-682-6100International dial-in: 862-298-0702Conference Call Name: Xtant Medical Q3 2021 Financial ResultsWebcast Registration: Click Here Following...

Tampa, FL, Nov. 05, 2021 (GLOBE NEWSWIRE) — via NewMediaWire — B2Digital Incorporated (the “Company” or “B2Digital”) (OTCMKTS:BTDG), the premier development league for mixed martial arts (“MMA”), is excited to announce that the B2 Fighting Series will roll into the Dayton Convention Center in Dayton, OH, this weekend for B2FS 138, which promises to be an exciting and action-packed MMA event showcasing top talent with next-level prospects. What:  B2 Fighting Series 138, Amateur and Professional LIVE MMAWhere:  Dayton Convention Center in Dayton, OhioWhen:  Saturday, November 6. Doors open at 6pm ET. PPV Broadcast starts at 7pm ET. In-person tickets for the event have nearly sold out, but interested fans can stream it live on Pay-Per-View here, or enjoy it live over the B2 Fighting Series apps on Amazon Fire TV or Apple TV. “The...

CUPERTINO, CA, Nov. 05, 2021 (GLOBE NEWSWIRE) — via NewMediaWire — Aemetis, Inc. (NASDAQ: AMTX) announced that the company will host a conference call to review the release of its third quarter 2021 earnings report: Date:   Thursday, November 11, 2021 Time:   11 am Pacific Standard Time (PST) Live Participant Dial In (Toll Free): +1-877-545-0523 access code 492308 Live Participant Dial In (International): +1-973-528-0016 access code 492308 Webcast URL: https://www.webcaster4.com/Webcast/Page/2211/43472 Attendees may submit questions during the Q&A portion of the conference call. After November 18th, the webcast will be available on the Company’s website (www.aemetis.com) under Investors/Conference Calls. The voice recording will also be available through November 18, 2021 by dialing (Toll Free) 877-481-4010 or (International)...

New Data at TCT From the Disrupt CAD Clinical Program Demonstrate Consistency of Shockwave IVL Outcomes Over Time, Across Calcium Morphologies and Between Genders SANTA CLARA, Calif., Nov. 05, 2021 (GLOBE NEWSWIRE) — Shockwave Medical, Inc. (NASDAQ: SWAV), a pioneer in the development of Intravascular Lithotripsy (IVL) to treat severely calcified cardiovascular disease, today unveiled new data confirming the safety and effectiveness of coronary IVL out to one year, a new gender analysis that found similar outcomes between men and women, and an OCT analysis that found consistent acute performance in eccentric, concentric and nodular calcified lesions. The data from the Disrupt CAD clinical program were presented in several sessions at the 32nd Transcatheter Cardiovascular Therapeutics (TCT) annual scientific symposium of the Cardiovascular...

HOUSTON, Nov. 05, 2021 (GLOBE NEWSWIRE) — Bio-Path Holdings, Inc., (NASDAQ: BPTH) a biotechnology company leveraging its proprietary DNAbilize® antisense RNAi nanoparticle technology to develop a portfolio of targeted nucleic acid cancer drugs, today announced that it will host a live conference call and audio webcast on Friday, November 12, 2021 at 8:30 a.m. ET to report financial results for the third quarter ended September 30, 2021 and to provide a business overview. To access the live conference call, please call (844) 815-4963 (domestic) or (210) 229-8838 (international) at least five minutes prior to the start time and refer to conference ID 6684508. A live audio webcast of the call will also be available on the Presentations section of the Company’s website, www.biopathholdings.com. An archived webcast will be available...

WATERTOWN, Mass., Nov. 05, 2021 (GLOBE NEWSWIRE) — Selecta Biosciences, Inc. (NASDAQ: SELB), a biotechnology company leveraging its clinically validated ImmTOR™ platform to develop tolerogenic therapies that selectively mitigate unwanted immune responses, today announced that it plans to host a conference call on Tuesday, November 9, 2021, at 8:30 a.m. ET to discuss its financial results for the quarter ended September 30, 2021 and provide a business update. Individuals may participate in the live call via telephone by dialing (844) 845-4170 (domestic) or (412) 717-9621 (international) and may access a teleconference replay for one week by dialing (877) 344-7529 (domestic) or (412) 317-0088 (international) and using confirmation code 10147803. Investors and the public can access the live and archived webcast of this call and a...